Special Issue "Research in Immune Responses to Vaccines Antigen during Influenza A Infection"
Deadline for manuscript submissions: closed (31 August 2021).
Interests: influenza virus; host-pathogen interaction; vaccines; immunology; asthma
Current vaccination strategies against influenza are clearly inadequate, primarily due to the ever-changing nature of the influenza viruses. Thus, a significant clinical need exists for better influenza vaccines that can provide broader and long-lasting protection not only in healthy individuals but also in highly susceptible groups such as the elderly. This Special Issue of Vaccines will cover all aspects of influenza vaccines in the hope that new ideas and latest results will aid development of better vaccination strategies against influenza infections.
Dr. Yoichi Furuya
Dr. Danushka Wijesundara
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Universal influenza vaccine